EUVIMEDEUVIMED entdecken
Crossref

Ultrashort Oncologic Whole-Body [ 18 F]FDG Patlak Imaging Using LAFOV PET

Joyce van Sluis, Johannes H van Snick, Andor W J M Glaudemans, Riemer H J A Slart, Walter Noordzij, Adrienne H Brouwers, Rudi A J O Dierckx, Adriaan A Lammertsma, Charalampos Tsoumpas, Ronald Boellaard

Journal of Nuclear Medicine · 2024

DOI: 10.2967/jnumed.124.267784 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2024. Verfasst von Joyce van Sluis und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; and j…. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Whole Body Imaging, Lung Neoplasms. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methods to shorten [18F]FDG Patlak PET imaging procedures ranging from 65-90 to 20-30 min after injection, using a population-averaged input function (PIF) scaled to patient-specific image-derived input function (IDIF) values, were recently evaluated. The aim of the present study was to explore the feasibility of ultrashort 10-min [18F]FDG Patlak imaging at 55-65 min after injection using a PIF combined with direct Patlak reconstructions to provide reliable quantitative accuracy of lung tumor uptake, compared with a full-duration 65-min acquisition using an IDIF.

Methods

Patients underwent a 65-min dynamic PET acquisition on a long-axial-field-of-view (LAFOV) Biograph Vision Quadra PET/CT scanner. Subsequently, direct Patlak reconstructions and image-based (with reconstructed dynamic images) Patlak analyses were performed using both the IDIF (time to relative kinetic equilibrium between blood and tissue concentration (t*) = 30 min) and a scaled PIF at 30-60 min after injection. Next, direct Patlak reconstructions were performed on the system console using only the last 10 min of the acquisition, that is, from 55 to 65 min after injection, and a scaled PIF using maximum crystal ring difference settings of both 85 and 322. Tumor lesion and healthy-tissue uptake was quantified and compared between the differently obtained parametric images to assess quantitative accuracy.

Results

Good agreement was obtained between direct- and image-based Patlak analyses using the IDIF (t* = 30 min) and scaled PIF at 30-60 min after injection, performed using the different approaches, with no more than 8.8% deviation in tumor influx rate value (Ki ) (mean difference ranging from -0.0022 to 0.0018 mL/[min × g]). When direct Patlak reconstruction was performed on the system console, excellent agreement was found between the use of a scaled PIF at 30-60 min after injection versus 55-65 min after injection, with 2.4% deviation in tumor Ki (median difference, -0.0018 mL/[min × g]; range, -0.0047 to 0.0036 mL/[min × g]). For different maximum crystal ring difference settings using the scan time interval of 55-65 min after injection, only a 0.5% difference (median difference, 0.0000 mL/[min × g]; range, -0.0004 to 0.0013 mL/[min × g]) in tumor Ki was found.

Conclusion

Ultrashort whole-body [18F]FDG Patlak imaging is feasible on an LAFOV Biograph Vision Quadra PET/CT system without loss of quantitative accuracy to assess lung tumor uptake compared with a full-duration 65-min acquisition. The ultrashort 10-min direct Patlak reconstruction with PIF allows for its implementation in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18Whole Body ImagingLung NeoplasmsHumansFemaleMaleMiddle AgedAgedImage Processing, Computer-AssistedPositron-Emission TomographyTime FactorsPositron Emission Tomography Computed TomographyRadiopharmaceuticals

Stichwörter der Autor:innen

LAFOVPET/CTPatlakparametric PETultrashort scan duration

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; and j.van.sluis@umcg.nl.
  • Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; and.
  • Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, location VUMC, Amsterdam, The Netherlands.

Zitieren

APA

van Sluis, J., van Snick, J. H., Glaudemans, A. W. J. M., Slart, R. H. J. A., Noordzij, W., Brouwers, A. H., Dierckx, R. A. J. O., Lammertsma, A. A., Tsoumpas, C., & Boellaard, R. (2024). Ultrashort Oncologic Whole-Body [ 18 F]FDG Patlak Imaging Using LAFOV PET. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.124.267784

Vancouver

van Sluis J, van Snick JH, Glaudemans AWJM, Slart RHJA, Noordzij W, Brouwers AH, et al. Ultrashort Oncologic Whole-Body [ 18 F]FDG Patlak Imaging Using LAFOV PET. Journal of Nuclear Medicine. 2024. doi:10.2967/jnumed.124.267784

BibTeX
@article{vanSluis2024,
  author = {van Sluis, Joyce and van Snick, Johannes H and Glaudemans, Andor W J M and Slart, Riemer H J A and Noordzij, Walter and Brouwers, Adrienne H and Dierckx, Rudi A J O and Lammertsma, Adriaan A and Tsoumpas, Charalampos and Boellaard, Ronald},
  title = {Ultrashort Oncologic Whole-Body [ 18 F]FDG Patlak Imaging Using LAFOV PET},
  journal = {Journal of Nuclear Medicine},
  year = {2024},
  doi = {10.2967/jnumed.124.267784}
}
Kostenlos starten →